Announcements Trials
Browse Landscape

Status

Terminated 2Completed 1

Sponsor Class

INDUSTRY 3

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Breast 3

Conditions

Neoplasm Metastasis 3Breast Neoplasms 3

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Biological Assay × Clear all
NCT00551278 2016-01-12

Validation Study Using the GeneSearch BLN Assay to Test Sentinel Lymph Nodes From Patients With Breast Cancer

Janssen Diagnostics, LLC

Completed
80 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00595023 2016-01-12

GeneSearch Breast Lymph Node (BLN) Assay Timing Study

Janssen Diagnostics, LLC

Terminated
233 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00595296 2016-01-12

GeneSearchâ„¢ Breast Lymph Node (BLN) Assay Post Approval Study

Janssen Diagnostics, LLC

Terminated
461 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡